BioCardia, Inc. (NASDAQ:BCDA) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2026 First Quarter Financial Results and Business Update Conference Call.
Biocardia Inc. (BCDA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pingora Partners Keith Ohnmeis | 120,382 | $149,274 | +237% | 0.09% |
| 2. | Citadel Investment Group Ken Griffin | 22,956 | $28,465 | -64% | 0% |
| 3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.93 | 5,400 | $5,022.00 | 381,115 | 2026-08-17 | Filing | |
| $0.92 | 1,900 | $1,748.00 | 375,785 | 2026-08-13 | Filing | |
| $0.78 | 5,000 | $3,900.00 | 373,885 | 2026-07-29 | Filing | |
| $0.83 | 500 | $415.00 | 368,885 | 2026-07-17 | Filing | |
| $0.86 | 1,500 | $1,290.00 | 368,385 | 2026-07-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.00 | 3,257 | $6,514.00 | 8,968 | 2024-12-20 | Filing | |
| $0.43 | 129,802 | $55,814.86 | 1,896,025 | 2024-01-19 | Filing | |
| $2.31 | 3,200 | $7,379.84 | 203,200 | 2020-11-27 | Filing | |
| $2.01 | 8,435 | $16,954.35 | 12,088 | 2020-11-02 | Filing | |
| $0.13 | 19,230,769 | $2,499,999.97 | 130,503,835 | 2016-12-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 397,594 | $493,017 | 0% | |
| 2. | 300,000 | $372,000 | 0.24% | |
| 3. | 124,591 | $154,493 | 0% | |
| 4. | 77,619 | $96,248 | 0% | |
| 5. | 66,664 | $82,662 | 0% |
News See All
BioCardia, Inc. (NASDAQ:BCDA) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia Year-end 2025 Financial Results and Business Update Conference Call.
BioCardia, Inc. (NASDAQ:BCDA) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the BioCardia Third Quarter Financial Results and Business Update Conference Call. All participants will be in listen-only mode.
BioCardia, Inc. (NASDAQ:BCDA) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia Second Quarter Financial Results and Business Update Conference call.
BioCardia, Inc. (NASDAQ:BCDA) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia First Quarter Financial Results and Business Update Conference Call.
BioCardia, Inc. (NASDAQ:BCDA) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia Year-End 2024 Financial Results and Business Update Conference Call. [Operator Instructions].
BioCardia, Inc. (NASDAQ:BCDA) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the BioCardia Third Quarter 2024 Financial Results and Business Update Conference Call.
BioCardia, Inc. (NASDAQ:BCDA) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon. And welcome to the BioCardia Second Quarter 2024 Financial Results and Business Update Conference Call.
BioCardia, Inc. (NASDAQ:BCDA) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the BioCardia First Quarter 2024 Financial Results and Business Update Conference Call.
Insiders Are Buying These 11 Penny Stocks
US stock market started the second quarter of 2024 in the red, driven by rising treasury yields, broader volatility and uncertainty around rate cuts as inflation remains sticky.
Hedge Fund Resource Center